John P. Kelley

Former Chief Executive Officer at Tenax Therapeutics, Inc.

John P. Kelley

John P. Kelley

Former Chief Executive Officer at Tenax Therapeutics, Inc.

Overview
Career Highlights

The Medicines Co.
Tenax Therapeutics, Inc.
Phyxius Pharma, Inc.

RelSci Relationships

393

Number of Boards

4

Birthday

1954

Age

66

Relationships
RelSci Relationships are individuals John P. Kelley likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Acorda Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Tenax Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Dermata Therapeutics LLC

Relationship likelihood: Strong

Former President-Americas Region at EUSA Pharma, Inc.

Relationship likelihood: Strong

Chief Medical Officer & Vice President-Global Medical Affairs at Grifols Therapeutics, Inc.

Relationship likelihood: Strong

Managing Director at Vatea Fund

Relationship likelihood: Strong

Executive Vice President of Commercial & Business Operations at Tenax Therapeutics, Inc.

Relationship likelihood: Strong

Principal & Founder at Institute For Efficient Management, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & President at The Medicines Co.

Relationship likelihood: Strong

Chief Executive Officer & President at IVERIC bio, Inc.

Relationship likelihood: Strong

Paths to John P. Kelley
Potential Connections via
Relationship Science
You
John P. Kelley
Former Chief Executive Officer at Tenax Therapeutics, Inc.
Education
B.A.

TO EDUCATE THROUGH A COMMITMENT TO ATTENTION, EXCEPTIONAL TEACHING, AND ACADEMIC EXCELLENCE.

M.B.A.

Rockhurst University’s Helzberg School of Management prepares leaders like you to make a positive difference in the world. It’s more than just business education as usual – it’s business with a conscience. That’s why we educate and develop leaders based upon the Jesuit tradition of learning, leadership and service.

Career History
Chief Executive Officer
2013 - 2017

Tenax Therapeutics, Inc. is a pharmaceutical company, which engages in the identification, development, and commercialization of novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Co-Founder
2011 - 2013

Phyxius Pharma, Inc., a subsidiary of Tenax Therapeutics, Inc., is a company headquartered in Chester, NJ. The firm provides pharmaceutical products. It was founded by John P. Kelley, Doug Randall and Douglas Hay. On 13 Nov 13 Life Newco, Inc. acquired Phyxius Pharma, Inc. for $32.66 million.

President & Chief Operating Officer
2004 - 2009

The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.

Transactions
Details Hidden

Tenax Therapeutics, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John P. Kelley. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John P. Kelley's profile does not indicate a business or promotional relationship of any kind between RelSci and John P. Kelley.